MarketIQ Analyst Report for The Ensign Group Inc

29222 RANCHO VIEJO RD., SUITE 127, SAN JUAN CAPISTRANO, CA, US
ENSG

Last Updated: 19 Sep 2024

Executive Summary

Ensign Group Inc. (ENSG) is a leading provider of post-acute care services, with a strong track record of growth and profitability. The company's fundamentals are solid, with high margins, strong cash flow, and a growing revenue base. Technically, the stock is in a bullish trend, with a positive 50-day and 200-day moving average. Analysts are bullish on ENSG, with a consensus price target of $155.6.

Company Overview

The Ensign Group provides a range of post-acute care services, including skilled nursing, assisted living, and home health care. The company operates over 250 facilities in 13 states. Ensign has a strong reputation for quality care, and its facilities have consistently received high ratings from regulatory agencies.

Fundamental Analysis

Ensign Group's fundamentals are strong. The company has a high profit margin (5.68%), a strong operating margin (8.3%), and a healthy return on assets (4.03%). The company's revenue has grown steadily in recent years, and analysts expect this trend to continue in the future.

Technical Analysis

Technically, ENSG is in a bullish trend. The stock is trading above its 50-day and 200-day moving averages, and the relative strength index (RSI) is above 50. This indicates that the stock is in a strong uptrend.

Short Term Outlook

In the short term, ENSG is expected to continue to perform well. The company's fundamentals are strong, and the technical indicators are positive. Analysts expect the stock to continue to rise in the coming months.

Long Term Outlook

In the long term, ENSG is expected to continue to grow its revenue and earnings. The company's aging population is driving demand for post-acute care services, and Ensign is well-positioned to capitalize on this trend.

Analyst Recommendations

Analysts are bullish on ENSG. The consensus price target is $155.6, which represents a potential upside of over 3% from the current price. Two analysts have a "Strong Buy" rating on the stock, two have a "Buy" rating, and one has a "Hold" rating.